Preimplantation genetic diagnosis for Pelizaeus–Merzbacher disease with testing for age-related aneuploidies
Authors: Verlinsky, Y.1; Rechitsky, S.1; Laziuk, K.1; Librach, C.2; Genovese, R.1; Kuliev, A.1
Source: Reproductive BioMedicine Online, Volume 12, Number 1, January 2006 , pp. 83-88(6)
Publisher: Reproductive Healthcare Ltd
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Pelizaeus–Merzbacher disease (PMD) is an X-linked recessive demyelinating disorder of the central nervous system, caused by mutations of the proteolipid protein 1 gene (PLP1 gene). As no specific therapy is available for PMD, preimplantation genetic diagnosis (PGD) may be a useful option for couples carrying this mutation. PGD was performed for a couple who had had one child with the L86P mutation in exon 3 of the PLP1 gene. Because of advanced maternal age, PGD for this single-gene disorder was performed together with testing for chromosomal abnormalities. Polar bodies and blastomeres were tested for the presence of maternal mutation and closely linked markers DXS8020 and PLP5′ (CA)n. The same blastomeres were also tested for the copy number of chromosomes 13, 16, 18, 21, 22, X and Y, and five chromosomally abnormal embryos were identified. A total of three embryos predicted to be unaffected and free of chromosomal disorder were transferred back to the patient, resulting in a twin pregnancy and the birth of two healthy female infants confirmed to be free of PMD, representing the first PGD for PMD combined with aneuploidy testing.Keywords: PCR-BASED ANEUPLOIDY TESTING; PELIZAEUS-MERZBACHER DISEASE; PLP1 GENE; POLAR BODY AND BLASTOMERE PCR ANALYSIS; PREIMPLANTATION GENETIC DIAGNOSIS; UNIPARENTAL DISOMY
Document Type: Research article
Affiliations: 1: Reproductive Genetics Institute, Chicago, IL, USA 2: Create IVF Program, Toronto, Ontario, Canada
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Click here for Page Help